The 20 Best Triple-Negative Breast Cancer Doctors Near Me in Texas, US

Dr. O'Shaughnessy is a Medical Oncologist that focuses on breast cancer prevention and treatment. She founded The School of Breast Oncology, a program providing a curriculum-based program focused exclusively on breast cancer clinical management. Dr. O'Shaughnessy attended medical school at Yale University School of Medicine in New Haven, CT. She then completed her Internal Medicine residency at Massachusetts General Hospital in Boston, MA and a Medical Oncology fellowship at National Cancer Institute in Bethesda, MD. She is co-chair of Breast Cancer Research, chair of Breast Cancer Prevention Research at Baylor Charles A. Sammons Cancer Center and a member of the Scientific Advisory Board for US Oncology Research Network. Dr. O'shaughnessy is rated as an Elite provider by MediFind in the treatment of Triple-Negative Breast Cancer. She is also highly rated in 14 other conditions, according to our data. Her clinical expertise encompasses Breast Cancer, Triple-Negative Breast Cancer, PIK3CA-Related Overgrowth Spectrum, Inflammatory Breast Cancer, and Tissue Biopsy. Dr. O'shaughnessy is board certified in Medical Oncology- American Board Of Internal Med/Medical Oncology, Internal Medicine- American Board Of Internal Med, Internal Medicine- American Board Of Internal Medicine, and Medical Oncology- American Board Of Internal Medicine.

Dr. Alastair Thompson is a surgical oncologist specializing in breast cancer. He is the Professor and Chief of the Division of Surgical Oncology, Section of Breast Surgery at Baylor College of Medicine, where he holds the Olga Keith Wiess Chair of Surgery. He also serves as Co-Director of the Lester and Sue Smith Breast Center and is Co-Associate Director for Clinical Research at the Dan L Duncan Comprehensive Cancer Center.Dr. Thomspon’s clinical interests include: ductal carcinoma in situ (DCIS); nipple and skin sparing mastectomy; breast conservation surgery; and sentinel lymph node biopsy. His research interests include: multidisciplinary patient care alongside “bench to bedside” studies; and innovative clinical trials in cancer. He initiated and led a successful breast cancer laboratory program; provided leadership for a cancer center in the United Kingdom; chaired the UK national breast cancer trials portfolio of 120 studies; and engaged in a range of pivotal roles in key drug, radiation therapy and surgical trials involving the UK, Europe, United States and Australia.Dr. Thompson also has preclinical and practical experience in the design, implementation, monitoring and reporting of early- to late-phase drug and medical device trials. Dr. Thompson received his MBChB in Medicine Surgery and medical degree in Molecular Biology from the University of Edinburgh in Edinburgh, Scotland. He completed his residency in general surgery at the Royal Infirmary of Edinburgh and a Research Fellowship at the Imperial Cancer Research Fund in Edinburgh.Dr. Thompson has co-chaired the Comparison of Operative to Monitoring and Endocrine Therapy (COMET) Trial for low-risk DCIS; and the National Cancer Institute (NCI)-Breast Cancer Steering Committee proposed “no surgery” clinical trial planning committee. He is a member of the NCI BOLD taskforce and has held leadership positions in the Translational Breast Cancer Research Consortium and SWOG Cancer Research Network.Dr. Thompson is also a member of the American Society of Clinical Oncology, Association of Breast Surgery, British Association of Surgical Oncology, British Breast Group, American Society of Breast Surgeons, American Association for Cancer Research, Moynihan Chirurgical Club, and the Society of Surgical Oncology. Dr. Thompson is rated as an Elite provider by MediFind in the treatment of Triple-Negative Breast Cancer. He is also highly rated in 6 other conditions, according to our data. His clinical expertise encompasses Breast Cancer, Triple-Negative Breast Cancer, Inflammatory Breast Cancer, Mastectomy, and Tissue Biopsy. Dr. Thompson is currently accepting new patients.

Dr. Radha Iyengar is the medical director of the Breast Center at Texas Health Presbyterian Hospital Allen. She obtained her undergraduate and medical degrees from the University of Florida and went on to complete a general surgery residency at the University of Texas Southwestern Medical School in Dallas. She then completed a Society of Surgical Oncology accredited breast fellowship at Emory University in Atlanta before returning to Texas.Dr. Iyengar is board-certified by the American Board of Surgery and is a Fellow of the American College of Surgeons. She is a member of the American College of Surgeons, Dallas Medical Society, American Society of Breast Surgeons, American Society of Breast Disease and American Society of Clinical Oncology. Dr. Iyengar is rated as an Advanced provider by MediFind in the treatment of Triple-Negative Breast Cancer. She is also highly rated in 15 other conditions, according to our data. Her clinical expertise encompasses Breast Cancer, Paget Disease of the Breast, Inflammatory Breast Cancer, Intraductal Papilloma, and Lymphadenectomy.

Jennifer Litton is an Oncologist practicing medicine in Houston, Texas. Dr. Litton is rated as an Elite provider by MediFind in the treatment of Triple-Negative Breast Cancer. She is also highly rated in 8 other conditions, according to our data. Her clinical expertise encompasses Breast Cancer, Triple-Negative Breast Cancer, Inflammatory Breast Cancer, and Paget Disease of the Breast.

Bora Lim is a Hematologist practicing medicine in Houston, Texas. Dr. Lim is rated as an Elite provider by MediFind in the treatment of Triple-Negative Breast Cancer. She is also highly rated in 5 other conditions, according to our data. Her clinical expertise encompasses Inflammatory Breast Cancer, Breast Cancer, Triple-Negative Breast Cancer, and Paget Disease of the Breast.

Dr. Walton Taylor is a general surgeon specializing in the care of patients with breast cancer and melanoma. He also performs general surgeries, including robotic and laparoscopic procedures.Dr. Taylor grew up in Dallas, Texas. He received his undergraduate degree from Vanderbilt University and attended medical school at the University of Texas Medical Branch in Galveston, Texas. After completing medical school, he returned to Dallas to complete his residency at UT Southwestern.Dr. Taylor is a former President of the American Society of Breast Surgeons. During his term as president, he oversaw the development of national guidelines for genetic testing and mammography. He continues to speak nationally on breast cancer, genetics, melanoma, and genomic testing.An active educator for fellow health care professionals, Dr. Taylor serves on Continuing Medical Education committees for the Texas Medical Association, the Accreditation Council for Continuing Medical Education, and is a member of Texas Health Physician Group's Board of Trustees and Credentialing Committee. He also aids in developing educational tools for surgeons.Dr. Taylor describes his patient-centered approach to practice with clarity and conviction. Our practice philosophy is to put patients first. We work to give next-day results to patients and provide easy access to our providers and medical staff. I give my personal cell phone number to every patient so they can contact me directly with any urgent needs or questions. We do not see patients as their medical condition, but rather we see them as people with their own unique circumstances. We are here to treat the whole person and not just focus on the medical problem. Our goal is to treat the condition and make the process as smooth as possible."". Dr. Taylor is rated as an Experienced provider by MediFind in the treatment of Triple-Negative Breast Cancer. He is also highly rated in 17 other conditions, according to our data. His clinical expertise encompasses Breast Cancer, Paget Disease of the Breast, Angiosarcoma, and Melanoma.

"Dr. Amelia Tower is a board-certified general surgeon with advanced training in breast surgical oncology. She is also certified to perform Hidden Scar breast cancer surgery, a technique that promotes reduced scarring and optimal healing. Since 2013, Dr. Tower has cultivated clinical and academic experience in the latest and most advanced surgical techniques for the treatment of benign and malignant breast diseases. Additionally, she has built a reputation of initiating and restructuring successful breast surgical oncology programs at the hospital and service line levels. Dr. Tower is committed to achieving the best possible outcome for each patient by developing individualized, multidisciplinary breast health and cancer care.Patient Testimonials</h5>WATCH NOW:</h5>Texas Health Breast Specialists Patient Testimonial - Liz Pettis</a>WATCH NOW:</h5>Texas Health Breast Specialists Patient Testimonial - Bobbi Berg</a>". Dr. Tower is rated as an Experienced provider by MediFind in the treatment of Triple-Negative Breast Cancer. She is also highly rated in 7 other conditions, according to our data. Her clinical expertise encompasses Breast Cancer, Paget Disease of the Breast, Angiosarcoma, Inflammatory Breast Cancer, and Lymphadenectomy.

Dr. Mothaffar F. Rimawi is a board-certified medical oncologist specializing in breast cancer care and research. He is Professor at the Department of Medicine, Section of Hematology and Oncology at Baylor College of Medicine. Dr. Rimawi is also Executive Medical Director & Associate Director of Clinical Affairs and Co-Leader of the Breast Cancer Program at BCM’s Dan L Duncan Comprehensive Cancer Center. Additionally, he serves as Chief of the Oncology Service Line at St Luke's Health in Houston.Dr. Rimawi’s professional interests include: the diagnosis, treatment and management of breast cancer; clinical trials in breast cancer; neoadjuvant therapy; targeted therapy and biomarkers in breast cancer; treatment resistance to ER and HER2-targeted therapies in breast cancer; locally advanced breast cancer; and breast disease and cancer.Dr. Rimawi received his medical degree from the University of Jordan in Amman, Jordan. He completed his residency in Internal Medicine and fellowships in Medical Oncology and Hematology and Breast Cancer at BCM. Dr. Rimawi holds certifications in Internal Medicine and Medical Oncology from the American Board of Internal Medicine. He is a member of the American College of Physicians, American Society of Clinical Oncology and the American Medical Association.In addition to English, Dr. Rimawi speaks Arabic. Dr. Rimawi is rated as a Distinguished provider by MediFind in the treatment of Triple-Negative Breast Cancer. He is also highly rated in 7 other conditions, according to our data. His clinical expertise encompasses Breast Cancer, HER-2 Positive Breast Cancer, Triple-Negative Breast Cancer, and Paget Disease of the Breast. Dr. Rimawi is currently accepting new patients.

Funda Meric is a General Surgeon and a Surgical Oncologist practicing medicine in Houston, Texas. Dr. Meric is rated as a Distinguished provider by MediFind in the treatment of Triple-Negative Breast Cancer. She is also highly rated in 19 other conditions, according to our data. Her clinical expertise encompasses PIK3CA-Related Overgrowth Spectrum, Breast Cancer, Cholangiocarcinoma (Bile Duct Cancer), Triple-Negative Breast Cancer, and Mastectomy.

Virginia Kaklamani is an Oncologist practicing medicine in San Antonio, Texas. Dr. Kaklamani is rated as a Distinguished provider by MediFind in the treatment of Triple-Negative Breast Cancer. She is also highly rated in 6 other conditions, according to our data. Her clinical expertise encompasses Breast Cancer, Triple-Negative Breast Cancer, Paget Disease of the Breast, and PIK3CA-Related Overgrowth Spectrum.

Joseph Heyne is a General Surgeon practicing medicine in Fort Worth, Texas. Dr. Heyne is rated as an Advanced provider by MediFind in the treatment of Triple-Negative Breast Cancer. He is also highly rated in 15 other conditions, according to our data. His clinical expertise encompasses Paget Disease of the Breast, Breast Cancer, Intraductal Papilloma, HER-2 Positive Breast Cancer, and Lymphadenectomy. Dr. Heyne is board certified in General Surgery- American Board Of Surgery/General Surgery and General Surgery- American Board Of Surgery.

Anita Chow is a General Surgeon and a Surgical Oncologist practicing medicine in Fort Worth, Texas. Dr. Chow is rated as an Advanced provider by MediFind in the treatment of Triple-Negative Breast Cancer. She is also highly rated in 15 other conditions, according to our data. Her clinical expertise encompasses Breast Cancer, Paget Disease of the Breast, Intraductal Papilloma, HER-2 Positive Breast Cancer, and Lymphadenectomy. Dr. Chow is board certified in General Surgery- American Board Of Surgery/General Surgery and General Surgery- American Board Of Surgery.

Kristi Mcintyre is a Hematologist and an Oncologist practicing medicine in Dallas, Texas. She has been practicing medicine for over 44 years. Dr. Mcintyre is rated as an Advanced provider by MediFind in the treatment of Triple-Negative Breast Cancer. She is also highly rated in 9 other conditions, according to our data. Her clinical expertise encompasses Breast Cancer, Paget Disease of the Breast, Febrile Neutropenia, and Agranulocytosis.

Dr. Shalini Makawita is an oncologist specializing in gastrointestinal and general medical oncology. She is Assistant Professor of Medicine - Hematology & Oncology at the Dan L Duncan Comprehensive Cancer Center at Baylor College of Medicine.Dr. Makawita’s clinical interests include: gastrointestinal medical oncology; clinical trials; and cancer biomarkers.Dr. Makawita received a B.S. and MSc from the University of Toronto. She received her medical degree from Wayne State University School of Medicine. She completed her residency in internal medicine at Baylor College of Medicine and a fellowship in Hematology and Oncology at M.D. Anderson Cancer Center.Dr. Makawita holds certifications from the American Board of Internal Medicine in Medical Oncology and Hematology. She is a member of the American Society of Clinical Oncology and American Society of Hematology. In 2021, Dr. Makawita received the ASCO Conquer Cancer Merit Award and an Excellence in Ambulatory Care commendation in 2018 from Baylor College of Medicine. Dr. Makawita is rated as an Advanced provider by MediFind in the treatment of Triple-Negative Breast Cancer. She is also highly rated in 3 other conditions, according to our data. Her clinical expertise encompasses Triple-Negative Breast Cancer, Cholangiocarcinoma (Bile Duct Cancer), Pancreatic Cancer, and Gastrointestinal Stromal Tumor. Dr. Makawita is currently accepting new patients.

Dr. Michelle Ludwig is a radiation oncologist. She is an Associate Professor of Radiation Oncology at the Dan L Duncan Comprehensive Cancer Center at Baylor College of Medicine. She is also an Adjunct Assistant Professor of Human Genetics & Environmental Sciences, Division of Epidemiology at the UTHealth School of Public Health in Houston.Dr. Ludwig completed undergraduate studies at Purdue University in Lafayette, Indiana and received her medical degree from Emory University School of Medicine in Atlanta. She received her MPH from the Emory Rollins School of Public Health in Atlanta and her Ph.D. from the University of Texas Health Science Center in Houston. She completed her residency at the M.D. Anderson Cancer Center and a clinical fellowship at The University of Texas, Houston Medical Program and M.D. Anderson Cancer Center. Dr. Ludwig is board-certified in Radiation Oncology by the American Board of Radiology. In addition to English, Dr. Ludwig speaks Spanish. Dr. Ludwig is rated as an Advanced provider by MediFind in the treatment of Triple-Negative Breast Cancer. She is also highly rated in 2 other conditions, according to our data. Her clinical expertise encompasses Cervical Cancer, Triple-Negative Breast Cancer, Neuroendocrine Carcinoma of the Cervix, and Breast Cancer. Dr. Ludwig is currently accepting new patients.

Dr. Dao is a Clinical Assistant Professor at Texas A&M College of Medicine at Texas A&M Health Science Center, Dallas. Dr. Dao completed her general surgery training and fellowship in breast surgery at Baylor University Medical Center in Dallas. She is currently the Program Director for the surgical breast fellowship at Baylor University Medical Center. She graduated in the top quarter of her medical school class at Texas A&M University, College of Medicine. Dr. Dao uses her background in psychology and cell biology to address complex problems in breast cancer surgery. She enjoys spending time with her patients to help them understand their disease and using her expertise to guide them. Her philosophy is “treat the whole patient” with a personalized and integrative approach. Her goal is to listen and work to address each patient’s concerns. She collaborates with patients to develop treatment plans that optimize physical, mental, and emotional health. With more than 15 years of surgical experience, Dr. Dao’s technique specializes in using hidden scar and oncoplastic surgical procedures to restore the natural breast and minimize the cosmetic defect of the tumor removal. Dr. Dao participates in clinical trials and research to bring new advances to the field of breast oncology. She received the Ralph Tompsett Writing Award and John Halverson Young Investigator Award for her research. Dr. Dao grew up in the Dallas/Ft. Worth area and briefly left Texas to attend college at UC Berkeley. (Go Bears!). She returned home to be close to her family. In her free time, she enjoys skiing, hiking, and spending beach vacations with her husband and two children. Dr. Dao is rated as an Advanced provider by MediFind in the treatment of Triple-Negative Breast Cancer. She is also highly rated in 10 other conditions, according to our data. Her clinical expertise encompasses Breast Cancer, Paget Disease of the Breast, Intraductal Papilloma, and Giant Mammary Hamartoma. Dr. Dao is board certified in General Surgery- American Board Of Surgery/General Surgery and General Surgery- American Board Of Surgery.

Dr. Ahmed Elkhanany specializes in the care of patients with breast cancer. He is an Assistant Professor of Medicine at the Lester and Sue Smith Breast Center at Baylor College of Medicine, where he is also a member of the Breast Cancer Prevention and High-Risk Clinic.Dr. Elkhanany’s clinical interests include breast cancer prevention and metastatic breast cancer. His research interests include: translational breast cancer genomics and impact of race and ethnicity on gene drivers of breast cancer. He is also involved with projects that translate lab-based findings to bedside novel treatment combinations in the hope of improving patient lives and finding novel, less toxic cures.Dr. Elkhanany received his medical degree from the Alexandria University School of Medicine in Egypt. He completed his residency in internal medicine at the University of Missouri-Kansas City and a fellowship in hematology and oncology at Roswell Park Comprehensive Cancer Center in Buffalo, New York. He also completed a post-doctoral felllowship in Triple Negative Breast Cancer at Mayo Clinic in Rochester, Minnesota.A member of the American Society of Clinical Oncology Dr. Elkhanany is board certified in internal medicine, hematology, and oncology. He is also the recipient of several teaching awards at the University of Alabama (UAB) at Birmingham, where he was previously Assistant Professor in the Department of Breast Oncology at UAB Medicine.In addition to English, Dr. Elkhanany speaks Arabic. Dr. Elkhanany is rated as an Advanced provider by MediFind in the treatment of Triple-Negative Breast Cancer. He is also highly rated in 5 other conditions, according to our data. His clinical expertise encompasses Breast Cancer, Inflammatory Breast Cancer, Paget Disease of the Breast, Angiosarcoma, and Tissue Biopsy. Dr. Elkhanany is currently accepting new patients.

Dr. Julie Nangia is a medical oncologist who specializes in the care of patients with breast cancer. Dr. Nangia is Medical Director of Breast Oncology at the Breast Care Center at the Dan L Duncan Comprehensive Cancer Center and an Associate Professor of Medicine at the Lester and Sue Smith Breast Center at Baylor College of Medicine. She is also the Director of the Breast Cancer Prevention and High Risk Clinic at BCM, where she is a Faculty Senator.Dr. Nangia’s clinical interests include: hereditary breast cancer, breast cancer prevention, and metastatic triple negative breast cancer.Dr. Nangia received her medical degree from the University of Missouri-Kansas City. She completed her residency in internal medicine at The University of Texas Health Science Center in Houston and a hematology-oncology fellowship at Rush University Medical Center in Chicago, Illinois.Dr. Nangia is board certified in internal medicine and medical oncology. Dr. Nangia is rated as an Advanced provider by MediFind in the treatment of Triple-Negative Breast Cancer. She is also highly rated in 8 other conditions, according to our data. Her clinical expertise encompasses Breast Cancer, Paget Disease of the Breast, Familial Pancreatic Cancer, and HER-2 Positive Breast Cancer. Dr. Nangia is currently accepting new patients.

Nuhad Ibrahim is an Oncologist practicing medicine in Houston, Texas. Dr. Ibrahim is rated as a Distinguished provider by MediFind in the treatment of Triple-Negative Breast Cancer. He is also highly rated in 9 other conditions, according to our data. His clinical expertise encompasses Breast Cancer, Inflammatory Breast Cancer, HER2 Negative Breast Cancer, and Triple-Negative Breast Cancer.

Carlos Barcenas is an Oncologist practicing medicine in Houston, Texas. Dr. Barcenas is rated as a Distinguished provider by MediFind in the treatment of Triple-Negative Breast Cancer. He is also highly rated in 4 other conditions, according to our data. His clinical expertise encompasses Breast Cancer, Inflammatory Breast Cancer, Triple-Negative Breast Cancer, Paget Disease of the Breast, and Colonoscopy.